Use of injectable concentrates of purified fibronectin in an attack of malignant malaria
Lefrère, J.J.; Prazuck, T.; Fisch, A.; Goepp, A.; Prou, O.; Dubarry, M.; Habibi, B.; Soulier, J.P.
Annales de Medecine Interne 138(2): 145-146
1987
ISSN/ISBN: 0003-410X PMID: 3555208 Document Number: 299053
Document emailed within 1 workday
Related Documents
Kasper, C.K.; Kim, H.C.; Gomperts, E.D.; Smith, K.J.; Salzman, P.M.; Tipping, D.; Miller, R.; Montgomery, R.M. 1991: In vivo recovery and survival of monoclonal-antibody-purified factor VIII concentrates Thrombosis and Haemostasis 66(6): 730-733Chamontin, B.; Guittard, J.; Laroche, M.; Boneu, B.; Salvador, M. 1984: Treatment of deep venous thrombosis in the presence of a congenital antithrombin IIi deficiency. Apropos of the use of purified concentrates Archives des Maladies du Coeur et des Vaisseaux 77(9): 1064-1067
Jopling, W.H. 1988: If i had an attack of malaria British Journal of Clinical Practice 42(2): 49-50
1992: Frontal attack on malaria Boletin de la Oficina Sanitaria Panamericana. Pan American Sanitary Bureau 113(5-6): 466-470
Louis, F.J.; Stanley, H.Morton. 2005: Malaria attack, I presume? Medecine Tropicale: Revue du Corps de Sante Colonial 65(4): 303
Ouaissi, A.; Dei-Cas, E.; Colin, J.J.; Ramage, C.; Muller, F.; Triboulet, J.P.; Vernes, A. 1986: Quantitative changes of plasma fibronectin in Plasmodium knowlesi malaria Pathologie-Biologie 34(3): 186-188
Mociková, K.; Vrlíková, Z.; Wildová, B.; Faber, E. 1989: Clinical evaluation of granulocyte concentrates in the treatment of malignant disorders of hematopoiesis Vnitrni Lekarstvi 35(1): 9-15
Hovette, P.; Camara, P.; Passeron, T.; Tuan, J.F.; Ba, K.; Barberet, G.; Moncade, F. 2002: Salmonella enteritidis splenic abscess complicating a Plasmodium falciparum malaria attack Presse Medicale 31(1 Part 1): 21-22
Muron, T.; Biron, F.; Boibieux, A.; Chi, N.H.; Piens, M.A.; Peyramond, D. 1991: Ideal treatment of malaria attack: more questions than answers? Experience of a department of infectious diseases Annales de Medecine Interne 142(4): 254-258
Adamsen, S.; Jönsson, P.; Brodin, B.; Lindberg, B.; Jorpes, P. 1991: Measurement of fibronectin concentration in benign and malignant ascites European Journal of Surgery 157(5): 325-328
Borkenstein, J.; Sommersgutter, M.; Hagenauer, E. 1986: Fibronectin in the sputum in malignant and inflammatory diseases of the respiratory tract Wiener Medizinische Wochenschrift 136(21-22): 543-545
Taylor-Papadimitriou, J.; Burchell, J.; Hurst, J. 1981: Production of fibronectin by normal and malignant human mammary epithelial cells Cancer Research 41(6): 2491-2500
Masuda, T.; Yamakado, T.; Nakano, T. 1994: Analysis of malignant ventricular arrhythmias during attack of vasospastic angina Nihon Rinsho. Japanese Journal of Clinical Medicine 52 Suppl (Part 2): 270-273
Warren, M.; Collins, W.E.; Jeffery, G.M.; Skinner, J.C. 1983: The seroepidemiology of malaria in Middle America. V. Antibody responses in an indicator population from an endemic area with attack phase antimalaria activities American Journal of Tropical Medicine and Hygiene 32(6): 1209-1215
Soulier, J.P.; Prou, O.; Allain, J.P. 1985: Severe drop in plasma fibronectin in severe forms of Plasmodium falciparum malaria Presse Medicale 14(21): 1199-1200
Smirnov, A.V. 1991: Distribution of type I, III, IV, V collagen and fibronectin in the extracellular matrix of malignant schwannomas (immuno-morphologic study) Arkhiv Patologii 53(1): 34-39
Riley, E.M.; Andersson, G.; Otoo, L.N.; Jepsen, S.; Greenwood, B.M. 1988: Cellular immune responses to Plasmodium falciparum antigens in Gambian children during and after an acute attack of falciparum malaria Clinical and Experimental Immunology 73(1): 17-22
Sundar, S.K.; Bergeron, J.; Menezes, J. 1984: Purified plasminogen activating factor produced by malignant lymphoid cells abrogates lymphocyte cytotoxicity Clinical and Experimental Immunology 56(3): 701-708
Nagelschmidt, M.; Becker, D.; Bönninghoff, N.; Engelhardt, G.H. 1987: Effect of fibronectin therapy and fibronectin deficiency on wound healing: a study in rats Journal of Trauma 27(11): 1267-1271
Husová, L.; Lata, J.; Husa, P. 1999: An attack of malignant hyperthermia caused by a combination of the effects of succinylcholine, increased physical exertion and alcohol abuse Vnitrni Lekarstvi 45(12): 716-719